Archives of General Internal Medicine

Reach Us +1 (202) 780-3397

Opinion Article - Archives of General Internal Medicine (2024) Volume 8, Issue 3

Vaccines and Immunization: A Comprehensive Overview of Immunological Principles

Andrea Husethroma *

Department of Public Health, North Dakota State University, United States

*Corresponding Author:
Andrea Husethroma
Department of Public Health, North Dakota State University, United States
E-mail: andreal.husethroma@ndsu.edu

Received: 28-May-2024, Manuscript No. AAAGIM-24-136829; Editor assigned: 30-May-2024, PreQC No. AAAGIM-24-136829 (PQ); Reviewed: 13-Jun-2024, QC No. AAAGIM-24-136829; Revised: 17-Jun-2024, Manuscript No. AAAGIM-24-136829 (R); Published: 24-Jun-2024, DOI:10.35841/aaagim-8.3.233

Citation: : Husethroma A. Vaccines and immunization: A comprehensive overview of immunological principles. Arch Gen Intern Med. 2024;8(3):233.

Visit for more related articles at Archives of General Internal Medicine

Introduction

Vaccines represent one of the most significant achievements in modern medicine, playing a crucial role in preventing infectious diseases and promoting public health. Immunization through vaccination harnesses the body's immune system to provide protection against specific pathogens, thereby reducing the incidence and severity of diseases. This article delves into the immunological principles underlying vaccines and immunization, exploring how vaccines work, the types of vaccines available, and the impact of vaccination programs on global health [1, 2].

To understand how vaccines work, it's essential to grasp the basics of the immune system. The immune system is a complex network of cells, tissues, and organs that work together to defend the body against harmful invaders like bacteria, viruses, fungi, and parasites. The immune response is typically categorized into two main types: innate immunity and adaptive immunity. Innate immunity is the body's first line of defense and responds quickly to invading pathogens. It consists of physical barriers like the skin and mucous membranes, as well as various immune cells such as macrophages, neutrophils, and natural killer cells. These components act to recognize and eliminate pathogens through mechanisms that do not rely on previous exposure to the pathogen [3, 4].

Adaptive immunity, also known as acquired immunity, is more specialized and involves the activation of lymphocytes (B cells and T cells). This branch of the immune system is characterized by its ability to remember previous encounters with specific pathogens, enabling a faster and more effective response upon subsequent exposures. This immunological memory is the foundation upon which vaccination is built. Antigens are molecules or molecular structures that are recognized by the immune system as foreign. Vaccines contain antigens derived from the pathogen they target. These antigens can be whole pathogens that have been killed or weakened, fragments of the pathogen, or synthetic components designed to mimic pathogen molecules. When a vaccine is administered, the antigens it contains are taken up by Antigen-Presenting Cells (APCs) such as dendritic cells. These APCs process the antigens and present them on their surface to T cells, a type of lymphocyte involved in the adaptive immune response. This presentation activates T cells, which in turn help activate B cells [5, 6].

Activated B cells differentiate into plasma cells that produce antibodies specific to the antigens introduced by the vaccine. Antibodies are proteins that can neutralize pathogens by binding to them and marking them for destruction by other immune cells. Some of the activated B and T cells become memory cells. These cells persist in the body long after the initial vaccination, providing long-term protection by rapidly responding to future exposures to the pathogen. Live attenuated vaccines use pathogens that have been weakened so they cannot cause disease in healthy individuals. These vaccines elicit strong and long-lasting immune responses. Examples include the Measles, Mumps, and Rubella (MMR) vaccine and the Oral Polio Vaccine (OPV) [7, 8].

Inactivated vaccines contain pathogens that have been killed, making them incapable of causing disease. These vaccines often require multiple doses to achieve sufficient immunity. Examples include the Inactivated Polio Vaccine (IPV) and the hepatitis A vaccine. These vaccines contain only specific pieces of the pathogen, such as proteins or sugars, which can trigger an immune response. They often require adjuvants to enhance their effectiveness. Examples include the hepatitis B vaccine and the Human Papillomavirus (HPV) vaccine. Toxoid vaccines contain inactivated toxins produced by the pathogen, which stimulate an immune response without causing harm. These are used to protect against diseases where bacterial toxins play a major role, such as tetanus and diphtheria. These are newer types of vaccines that use genetic material to instruct cells to produce antigens. mRNA vaccines, such as those for COVID-19 (Pfizer-BioNTech and Moderna), use messenger RNA to encode the antigen. Vector-based vaccines, like the Johnson & Johnson COVID-19 vaccine, use a harmless virus to deliver genetic instructions [9, 10].

Conclusion

Vaccines are a cornerstone of modern medicine, leveraging immunological principles to protect against infectious diseases. By understanding how vaccines stimulate the immune system and the different types of vaccines available, we can appreciate the profound impact of immunization on public health. Continued investment in vaccination programs and overcoming challenges will ensure that the benefits of vaccines reach every corner of the globe, safeguarding the health of future generations.

References

  1. Dinleyici EC, Borrow R, Safadi MA, et al. Vaccines and routine immunization strategies during the COVID-19 pandemic. Hum Vaccin Immunother. 2021;17(2):400-7.

    2. Indexed at, Google Scholar, Cross Ref

  2. Sellars MC, Wu CJ, Fritsch EF. Cancer vaccines: Building a bridge over troubled waters. Cell. 2022;185(15):2770-88.

    3. Indexed at, Google Scholar, Cross Ref

  3. Geckin B, Föhse FK, Netea MG, et al. Trained immunity: implications for vaccination. Curr Opin Immunol. 2022;77:102190.

    4. Indexed at, Google Scholar, Cross Ref

  4. Ma J, Li Z, Sun Y, et al. Improving innovation and access to combination vaccines for childhood immunization in China. Int J Environ Res Public Health. 2022;19(23):15557.

    5. Indexed at, Google Scholar, Cross Ref

  5. Ward JK, Verger P, MacDonald NE, et al. Vaccine hesitancy, acceptance, and anti-vaccination: trends and future prospects for public health. Annu Rev Public Health. 2021;42(1):175-91.

    6. Indexed at, Google Scholar, Cross Ref

  6. Primorac D, Vrdoljak K, Brlek P, et al. Adaptive immune responses and immunity to SARS-CoV-2. Front Immunol. 2022;13:848582.

    7. Indexed at, Google Scholar, Cross Ref

  7. Hill A, Beitelshees M, Pfeifer BA. Vaccine delivery and immune response basics. Methods Mol Biol. 2021:1-8.

    8. Indexed at, Google Scholar, Cross Ref

  8. Bonanni P, Steffen R, Schelling J, et al. Vaccine co-administration in adults: An effective way to improve vaccination coverage. Hum Vaccin Immunother. 2023;19(1):2195786.

    9. Indexed at, Google Scholar, Cross Ref

  9. Conklin L, Hviid A, Orenstein WA, et al. Vaccine safety issues at the turn of the 21st century. BMJ Glob Health. 2021;6(2):004898.

    10. Indexed at, Google Scholar, Cross Ref

  10. Verma SK, Mahajan P, Singh NK, et al. New-age vaccine adjuvants, their development, and future perspective. Front Immunol. 2023;14:1043109.

    11. Indexed at, Google Scholar, Cross Ref

Get the App